Why is Hemo Organic falling/rising?

As of 30-Sep, Hemo Organic Ltd's stock is currently priced at Rs 9.50, reflecting a decrease of 1.0 or 9.52%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 10.38% during this period. It opened with a loss of 2% today and reached an intraday low of Rs 9.50. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume decreasing by 93.78% compared to the 5-day average. The company has a negative book value and a weak long-term fundamental strength, characterized by poor growth in net sales and a high debt-to-equity ratio, which further contributes to the stock's decline.
In the broader market context, Hemo Organic's short-term performance has been relatively better than the benchmark, with a 1-week return of 4.40% compared to the Sensex's decline of 2.23%. However, over the longer term, the stock has consistently underperformed against the benchmark, generating a return of -22.07% in the past year while the Sensex has increased by 2.72%. This consistent underperformance, coupled with negative EBITDA and a lack of institutional support, paints a concerning picture for potential investors, reinforcing the stock's downward trajectory.